Aptamers Market to be dominated by DNA Aptamers through 2028
The growing prevalence of
chronic and rare diseases is expected to drive the growth of Global Aptamers
Market in the forecast period, 2024-2028.
According to TechSci Research report, “Aptamers Market - Global Industry Size, Share, Trends, Opportunity, and
Forecast, 2018-2028”,
global aptamers market is anticipated
to grow at a steady rate in the forecast period, 2024-2028. This can be
ascribed to the growing usage of aptamers in different field such as research,
diagnostics, medicine, among others. Additionally, growing demand for low-cost
product and increasing research activities in the pharmaceutical and
biotechnology industries is expected to boost the growth of the market during
the forecasted period. Also, rapid rise in the infectious diseases across the
globe along with grow will further enhance the demand for the aptamers market
in the forecasted period. Besides, growing research activities to evaluate the
mechanism of action of nucleic acid aptamers to treat age related macular
degeneration is further expected to support the market growth during the
forecast period. Also, growing advancements in the generation, purification and
drug delivery for killing the target cells have attracted the attention of many
researchers towards aptamers due to competitive advantages associated with them
will further drive the growth of the market during the forecasted period.
However, the
lack of proper guidelines on molecular development along with shortage of
trained and expert professionals may slow down the growth of the global aptamers
market in the forecast period. Also, the low adoption rates and lack of
awareness about the latest technologies in middle- and low-income countries may
hamper the growth of the market during the forecast period. Additionally, improper
regulatory structure and problem regarding the efficiency and safety standards
over clinical studies can further restrict the growth of the global aptamers market.
Browse over XX market data Figures
spread through XX
Pages and an in-depth TOC on "Aptamers Market"
Aptamers market can be segmented by type,
technology, application, end user and region.
Based on type, the global aptamers market can
be segmented into DNA Aptamers, XNA Aptamers, RNA Aptamers. The DNA Aptamers segment dominated the market in 2022 and is
expected to continue maintaining its dominance throughout the forecast period.
This can be ascribed to the growing demand for lower production cost and higher
stability compared to other acid based nucleic acid based aptamers and easy
availability of DNA aptamers. Also, growing application in in diagnostic and
therapeutic purposes will be expected to drive the growth of the market during
the forecasted period.
Based on application, the market can be segmented
into therapeutics development,
research & development, diagnostics, and others. The therapeutic development segment is
expected to dominate during the forecast period on account of the increasing number
of clinical trials assessing aptamers for new therapies along with
collaborative partnerships between aptamer companies and prominent
pharmaceutical and biopharmaceutical firms due to the growing prevalence of
chronic diseases and the development of new diagnostics kits for detection of
cancer and other diseases will further drive the growth of the market during
the forecasted period.
Major companies operating in the global aptamers
market are:
- Aptamer Group
- Raptamer Discovery Group
- Somalogic Inc.
- Aptamer Sciences, Inc.
- Aptagen LLC.
- Maravai Lifesciences.
- Kaneka Corporation.
- Neoventures
Biotechnology Inc.
- Aptus
Biotech.
- Base
Pair Biotechnologies.
Various companies operating in the market are
following strategies such as mergers & acquisitions, collaborations &
partnerships, among others in order to stay competitive and have an edge over
other market players. Additionally, companies are developing kits, and
treatments using aptamers. For instance, in February 2019, Base Pair
Biotechnologies Inc developed point of care tests to diagnose neonatal
abstinence syndrome based on aptamer with the SBIR grants assistance. Also, in
January 2019, Aptamer Group announced that the AstraZeneca Company has agreed
to collaborate to expand the aptamer technology application potential. With
this collaboration, AstraZeneca will adapt to the aptamer groups technology to
improve the advanced drug delivery vehicles named after aptamer drug
conjugates.
Download Free Sample Report
Customers can also request
for 10% free customization on this report.
“North America is
expected to dominate in the global aptamers market due to the growing
prevalence of chronic diseases across the region especially in the United
States. Additionally, well established healthcare and pharmaceutical
infrastructure within the region is further supporting the growth of aptamers
market. Similarly, the growing interest of research laboratories in the
aptamers fields is further expected to support the market growth during the
forecast period.” said Mr. Karan Chechi, Research Director with TechSci
Research, a research-based global management consulting firm.
“Aptamers Market - Global Industry Size, Share, Trends,
Opportunity, and Forecast, 2018-2028 Segmented By Type (DNA Aptamers, XNA Aptamers, RNA Aptamers), By Technology
(SELEX, Others), By Application (Therapeutics
Development, Research & Development, Diagnostics, Others), By End User
(Pharmaceutical & Biotechnology Companies, Academic & Research Institutions,
Contract Research Organizations, Others), By Region and Competition”, has evaluated the future growth potential of global aptamers
market and provides statistics & information on market size, structure, and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision-makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in the global aptamers market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com